Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1952 1
1954 1
1955 1
1959 1
1961 1
1963 2
1978 1
1981 3
1982 2
1983 1
1984 1
1985 1
1986 3
1987 1
1988 1
1989 2
1990 2
1991 6
1992 3
1993 3
1994 4
1995 1
1997 1
1998 2
1999 5
2000 5
2001 6
2002 9
2003 8
2004 14
2005 12
2006 31
2007 31
2008 33
2009 39
2010 30
2011 51
2012 51
2013 59
2014 87
2015 102
2016 108
2017 118
2018 120
2019 135
2020 211
2021 183
2022 220
2023 257
2024 343
2025 326
2026 257

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,635 results

Results by year

Filters applied: . Clear all
Page 1
Early Tirofiban Infusion after Intravenous Thrombolysis for Stroke.
Tao C, Liu T, Cui T, Liu J, Li Z, Ren Y, Zhao X, Xie F, Li J, Wang H, Huang L, Li J, Wen J, Zeng J, Zhu J, Li Z, Li D, Hu X, Huang B, Wang J, Zhang C, Ye B, Hou Y, Gan Y, Sun H, Guan F, Shao Y, Liu Z, Ou Z, Fan S, Wang Y, Zhai H, Ni C, Wang H, Zhang C, Zhao Y, Wang G, Zhu Y, Li R, Sun J, Hu H, Cui J, Wang L, Zhang C, Song J, Jing X, Wang A, Wang J, Xu P, Qureshi AI, Nguyen TN, Nogueira RG, Saver JL, Hu W; ASSET-IT Investigators. Tao C, et al. N Engl J Med. 2025 Sep 25;393(12):1191-1201. doi: 10.1056/NEJMoa2503678. Epub 2025 Jul 4. N Engl J Med. 2025. PMID: 40616232 Clinical Trial.
Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells.
Zhu GQ, Tang Z, Chu TH, Wang B, Chen SP, Tao CY, Cai JL, Yang R, Qu WF, Wang Y, Zhao QF, Huang R, Tian MX, Fang Y, Gao J, Wu XL, Zhou J, Liu WR, Dai Z, Shi YH, Fan J. Zhu GQ, et al. Among authors: tao cy. Signal Transduct Target Ther. 2025 Jan 22;10(1):25. doi: 10.1038/s41392-024-02118-2. Signal Transduct Target Ther. 2025. PMID: 39837814 Free PMC article.
Endovascular Treatment of Medium-Vessel-Occlusion Strokes.
Hu W, Jing X, Chen Z, Zheng J, Yi T, Zheng T, Li Z, Liu J, Cui T, Wen J, Feng G, Song C, Yang L, Jiang S, Tong L, Jiang C, Ruan Z, Zhou P, Wang S, Wang T, Zhou Z, Ren Y, Qiu T, Zheng C, Wang H, Liu Y, Luo Y, Wang J, Ma Z, Mei B, Liang Y, Zhu Y, Li R, Sun J, Wang L, Zhang C, Liu T, Song J, Tao C, Wang A, Wang J, Xu P, Guo X, Shu L, Qureshi AI, Nguyen TN, AbdalKader M, Saver JL, Chen W, Nogueira RG. Hu W, et al. Among authors: tao c. N Engl J Med. 2026 May 14;394(19):1894-1904. doi: 10.1056/NEJMoa2514120. N Engl J Med. 2026. PMID: 42127389 Clinical Trial.
Targeting HMGB2 acts as dual immunomodulator by bolstering CD8+ T cell function and inhibiting tumor growth in hepatocellular carcinoma.
Qu WF, Zhu GQ, Yang R, Chu TH, Guan ZQ, Huang R, Tian MX, Jiang XF, Tao CY, Fang Y, Gao J, Wu XL, Chen JF, Zhao QF, Wang Y, Bu YC, Zhou J, Fan J, Liu WR, Tang Z, Shi YH. Qu WF, et al. Among authors: tao cy. Sci Adv. 2025 May 2;11(18):eads8597. doi: 10.1126/sciadv.ads8597. Epub 2025 May 2. Sci Adv. 2025. PMID: 40315321 Free PMC article.
2,635 results